Bayer has won the auction for Merck & Co's consumer care business with a cash offer of $14.2bn. The companies also plan to collaborate in the field of sGC (soluble guanylate cyclase) modulators, for which Merck will make an upfront payment to Bayer of $1bn.
Bayer CEO Dr Marijn Dekkers said that the current wave of M&A activity in the pharmaceutical sector "is being driven...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
